Nuvation Bio (NUVB)
NYSE:NUVB
US Market
Holding NUVB?
Track your performance easily

Nuvation Bio (NUVB) Financial Statements

166 Followers

Nuvation Bio Financial Overview

Nuvation Bio's market cap is currently ―. The company's EPS TTM is $-2.11; its P/E ratio is -1.37; Nuvation Bio is scheduled to report earnings on October 31, 2024, and the estimated EPS forecast is $-0.14. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 1.44M----
Gross Profit$ 88.00K----
EBIT$ -462.36M$ -20.20M$ -20.83M$ -19.65M$ -20.64M
EBITDA$ -462.12M$ -20.14M$ -20.78M$ -23.02M$ -23.80M
Net Income Common Stockholders$ -462.49M$ -14.79M$ -13.79M$ -18.55M$ -20.64M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 577.17M$ 596.98M$ 611.21M$ 619.34M$ 630.90M
Total Assets$ 594.80M$ 613.13M$ 621.48M$ 630.87M$ 641.41M
Total Debt$ 14.68M$ 3.53M$ 4.01M$ 4.46M$ 3.68M
Net Debt$ -562.49M$ -593.44M$ -607.21M$ -614.88M$ -627.22M
Total Liabilities$ 62.66M$ 19.08M$ 16.36M$ 19.28M$ 16.78M
Stockholders Equity$ 532.12M$ 594.04M$ 605.12M$ 611.59M$ 624.60M
Cash Flow-
Free Cash Flow$ -37.30M$ -15.73M$ -15.04M$ -16.21M$ -17.54M
Operating Cash Flow$ -37.30M$ -15.70M$ -15.03M$ -16.18M$ -17.52M
Investing Cash Flow$ 34.27M$ 7.54M$ 33.16M$ -9.59M$ 37.35M
Financing Cash Flow$ 2.75M$ 21.00K$ 120.00K$ 77.00K$ 133.00K
Currency in USD

Nuvation Bio Earnings and Revenue History

Nuvation Bio Debt to Assets

Nuvation Bio Cash Flow

Nuvation Bio Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis